Showing results (41-50 of 46) with videos related to
Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 46 results.
Breast (Edinburgh, Scotland)|September 25, 2013
Circulating tumor cells and response to neoadjuvant paclitaxel and HER2-targeted therapy: a sub-study from the NeoALTTO phase III trialHatem A Azim, Francoise Rothé, Claudia Monica Aura, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 7, 2015
PIK3CA mutations are associated with decreased benefit to neoadjuvant human epidermal growth factor receptor 2-targeted therapies in breast cancerIan J Majewski, Paolo Nuciforo, Lorenza Mittempergher, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 4, 2015
Postoperative Adjuvant Lapatinib and Concurrent Chemoradiotherapy Followed by Maintenance Lapatinib Monotherapy in High-Risk Patients With Resected Squamous Cell Carcinoma of the Head and Neck: A Phase III, Randomized, Double-Blind, Placebo-Controlled StudyKevin Harrington, Stephane Temam, Hisham Mehanna, et al.The Journal of Biological Chemistry|December 24, 2002
The orphan G protein-coupled receptor GPR40 is activated by medium and long chain fatty acidsCelia P Briscoe, Mohammad Tadayyon, John L Andrews, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 22, 2025
INDUCE-3: A randomized Phase II/III study of first-line feladilimab plus pembrolizumab in patients with recurrent/metastatic head and neck squamous cell carcinomaDanny Rischin, Aaron R Hansen, Ezra E W Cohen, et al.Cancer Research Communications|August 18, 2023
Activating Inducible T-cell Costimulator Yields Antitumor Activity Alone and in Combination with Anti-PD-1 Checkpoint BlockadeSapna Yadavilli, Jeremy D Waight, Sara Brett, et al.Pageof 5